Search for: "D&S, Inc." Results 7581 - 7600 of 26,064
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
According to the Wall Street Journal, Pfizer Inc released a public statement on Saturday, January 6, 2018, announcing the end of R & D for new drugs for treatment of Alzheimer's Disease and Parkinson's Disease. [read post]
5 Jan 2018, 6:02 am
Posted by HLS Forum on Corporate Governance and Financial Regulation, on Friday, January 5, 2018 Editor's Note: This roundup contains a collection of the posts published on the Forum during the week of December 29, 2017-January 4, 2018. [read post]
5 Jan 2018, 5:35 am by Cynthia Marcotte Stamer
§164.308(a)(1)(ii)(D); 21CO disclosed protected health information to a third party vendors, acting as its business associates, without obtaining satisfactory assurances in the form of a written business associate agreement in violation of HIPAA’s business associate rule requirements under 45 C.F.R. [read post]
4 Jan 2018, 12:07 pm by Camilla Alexandra Hrdy
See T-MOBILE USA, INC. v.Huawei Device USA, Inc., 115 F.Supp.3d 1184 (2015) (DTSA/UTSA case).Example 2. [read post]
4 Jan 2018, 12:07 pm by Camilla Alexandra Hrdy
See T-MOBILE USA, INC. v.Huawei Device USA, Inc., 115 F.Supp.3d 1184 (2015) (DTSA/UTSA case).Example 2. [read post]
4 Jan 2018, 10:59 am by John Delaney and Aaron Rubin
In addition to security token sales that proceed under Regulation D or Regulation S exemptions from registration, I predict that we will see some token sales that are launched as registered securities offerings, as well as a number of blockchain-related companies that explore mini-IPOs under Reg A+. [read post]
4 Jan 2018, 10:04 am by Schachtman
Md. 2002) (excluding Hardell’s proposed testimony), aff’d, 78 Fed. [read post]
The cases, listed newest to oldest, and the Court’s summaries are as follows: Union of Medical Marijuana Patients, Inc. v. [read post]
3 Jan 2018, 2:05 pm
Il n'était de la sorte pas susceptible d'appel. [read post]
2 Jan 2018, 5:08 pm by Kevin LaCroix
I have set out below the Top Ten D&O stories of 2017, with an eye to these future possibilities. 1. [read post]